SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-20-006789
Filing Date
2020-06-18
Accepted
2020-06-18 17:01:34
Documents
2
Period of Report
2020-06-16
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ndra_8k.htm 8-K 45141
2 CERTIFICATE OF AMENDMENT ndra_ex31.htm EX-3.1 9022
  Complete submission text file 0001654954-20-006789.txt   55497
Mailing Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105
Business Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105 734-335-0468
ENDRA Life Sciences Inc. (Filer) CIK: 0001681682 (see all company filings)

IRS No.: 260579295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37969 | Film No.: 20973349
SIC: 3845 Electromedical & Electrotherapeutic Apparatus